Regional Radiotherapy in Head and Neck Non-melanoma Skin Cancer
Author(s)
Smith, J; Porceddu, SV;
Journal Title
In: Joseph, K. J., Veness, M. J., Barnes, E., Rembielak, A (eds). Radiotherapy in Skin Cancer: A Practical Guide on Indications and Techniques
Publication Type
Book section
Abstract
A proportion of patients diagnosed with a non-melanoma skin cancer (NMSC) present with, or develop, regional metastasis, most frequently in the head and neck region. Optimal management of NMSC with metastatic regional disease involves surgery and adjuvant radiotherapy (RT). Elective nodal RT may occasionally be considered in select cases with a high-risk primary character. The addition of chemotherapy to RT in locoregionally advanced cutaneous squamous cell carcinoma (cSCC) of the head and neck region has demonstrated no survival benefit in randomised studies. Adjuvant immunotherapy after surgery and RT remains an area of active investigation with multiple ongoing trials.
Publisher
Springer International Publishing
Department(s)
Radiation Oncology
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2025-05-01 08:11:44
Last Modified: 2025-05-01 08:12:28

© 2025 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙